Embla Medical hf.

Total Valuation

Embla Medical hf. carries a market capitalization of 1.77B, placing it among publicly traded companies globally. Its enterprise value stands at 2.23B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Embla Medical hf. currently has 426.01M shares outstanding.

Valuation Ratios

Embla Medical hf. trades at a trailing price-to-earnings ratio of 24.04. The price-to-sales ratio is 2.01, and the price-to-book ratio stands at 2.20.

Enterprise Valuation

On an enterprise value basis, Embla Medical hf. trades at an EV/EBITDA multiple of 18.67 and an EV/FCF ratio of 13.13. The EV/Sales ratio of 2.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.67 provides insight into valuation relative to core operating earnings.

Financial Position

Embla Medical hf. maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 67.67, indicating elevated leverage, while an interest coverage ratio of 5.29 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Embla Medical hf. posts a return on equity of 9.54 and a return on invested capital of 6.68.

Taxes

Over the trailing twelve months, Embla Medical hf. has paid 22.62M in income taxes, reflecting an effective tax rate of 23.48.

Stock Price Statistics

Embla Medical hf.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 4.15, while the 200-day moving average is 4.75.

Income Statement

Over the trailing twelve months, Embla Medical hf. generated 873.51M in revenue and converted that into 73.14M in net income, yielding earnings per share of 0.17. EBITDA reached 119.62M, while operating income came in at 119.62M.

Balance Sheet

Embla Medical hf. holds 95.20M in cash and equivalents against 565.69M in total debt, resulting in a net debt position of 298.85M. Total book value stands at 799.47M, with working capital of 198.70M providing operational flexibility.

Cash Flow

Embla Medical hf. produced 119.56M in operating cash flow over the past twelve months. After subtracting -33.25M in capital expenditures, free cash flow totaled 86.31M - equivalent to 0.20 per share.

Margins

Embla Medical hf. operates with a gross margin of 62.73, reflecting its pricing power and cost economics. The operating margin of 13.69 and net profit margin of 8.37 provide insight into operational efficiency.

Dividends & Yields

Scores

Embla Medical hf. posts an Altman Z-Score of 4.69, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.